The National Rosacea Society Research Grants fund studies on the biological, genetic, and mechanistic causes of rosacea to advance understanding and improve patient outcomes.
Funder: National Rosacea Society
Due Dates (Anticipated): July 2027 (Research grant full application submission deadline, projected)
Funding Amounts: Up to $25,000 per award (higher in special cases); typically one-year duration.
Summary: Supports research on the causes, mechanisms, and broader impacts of rosacea, with emphasis on pathogenesis, progression, and genetics.
Key Information: Product development studies (drug/device testing) are not funded; grants are available to researchers worldwide.
The National Rosacea Society Research Grants program funds scientific investigations aimed at advancing understanding of rosacea, a common but poorly understood skin disorder. Priority is given to studies that explore the pathogenesis, progression, mechanism of action, cell biology, and potential genetic factors underlying rosacea. The program also welcomes proposals examining epidemiology, predisposition, quality of life, and environmental or lifestyle associations with rosacea. The ultimate goal is to clarify the origins and biological processes of the disease and improve its management, prevention, and potential cure. Product development studies, such as drug or device testing, are not eligible for funding.